Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEMO trial of moxifloxacin plus metronidazole versus piperacillin/tazobactam for intra-abdominal abscesses
2005-002634-35Phase 3Completed
- Sponsor
- Department of General, Visceral and Transplant Surgery, Hannover Medical School
- Start
- Jul 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of moxifloxacin, metronidazole and tazobactam in intra-abdominal abscess (IAA) (2 arms), sponsored by Department of General, Visceral and Transplant Surgery, Hannover Medical School. Primary endpoint: Clinical success/failure at test-of-cure. Started Jul 2005; status: completed.
02
Drugs
moxifloxacinmetronidazoletazobactam
03
Conditions
intra-abdominal abscess (IAA)
Beyond the preview
Go deeper on 2005-002634-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002634-35.